Sort
48,018 grants matching “immunotherapy”
CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM
$385,560Fox Chase Cancer Center · K12 · FY2000 · CA
T. forsythia TLR2 ligands and surface glycans coordinate periodontal inflammation
$385,527Ashu Sharma · State University Of New York At Buffalo · R01 · FY2015 · DE
Localizing Immunotherapy to Improve Therapeutic Index
$385,527Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2014 · CA
Interleukin-2 and autoimmune disease
$385,521Abul K. Abbas · University Of California, San Francisco · R01 · FY2008 · AI
Pathogenesis of Experimental Autoimmune Myocarditis
$385,510David M. Engman · Northwestern University At Chicago · R01 · FY2008 · HL
Deciphering the function of DNp63 and MDSCs in tumor promotion and metastasis of TNBCs
$385,475Rumela Chakrabarti · University Of Pennsylvania · R01 · FY2019 · CA
Mitochondrial stress promotes immunosuppressive potential of myeloid subsets in tumors
$385,444Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
High Efficiency Microfluidic Device for Large Scale CAR-T Cell Manufacturing
$385,433Lotien Richard Huang · Cg Scientific, Inc. · R43 · FY2020 · CA
Immune Response to Polyomavirus Infection
$385,400Parmjeet S Randhawa · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · AI
Alternative MHCII Processing of Influenza Virus Proteins
$385,315Laurence Crane Eisenlohr · Children'S Hosp Of Philadelphia · R01 · FY2015 · AI
MULTI-EPITOPE MELANOMA VACCINES FOR CD4 AND CD8 T-CELLS
$385,303Craig Lee Slingluff · University Of Virginia · R01 · FY2007 · CA
Immunotherapeutics to Prevent &Treat BoNT Intoxication
$385,286University Of California Los Angeles · U01 · FY2004 · AI
SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responses
$385,224Kirill A Afonin · University Of North Carolina Charlotte · R35 · FY2022 · GM
DEVELOPMENT & EVALUATION OF PRACTICABLE APPROACHES FOR GENERATION OF CYTOTOXIC &
$385,179Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
ANTIBODY-BASED THERAPY FOR METHAMPHETAMINE ABUSE
$385,124University Of Arkansas Med Scis Ltl Rock · R01 · FY2001 · DA
Cell lineage as an indicator of immune response in neuroblastoma
$385,110Rani E George · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Targeting metastatic tumors with engineered cellular therapies
$385,097Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2024 · CA
Chemokine Modulation During SIV Infection &AIDS
$385,050University Of Pittsburgh At Pittsburgh · R01 · FY2005 · AI
Immunotherapy for Drug Abuse
$385,040S. Michael Owens · Univ Of Arkansas For Med Scis · R01 · FY2009 · DA
Melanoma-associated retinopathy: detection and mechanisms
$385,000Catherine W Morgans · Oregon Health & Science University · R01 · FY2023 · EY
Engineered B Cells as a Universal Platform for the Treatment of Enzymopathies
$385,000Branden S Moriarity · University Of Minnesota · R01 · FY2020 · AI
Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy
$385,000Martin McMahon · University Of Utah · R01 · FY2024 · CA
The non-canonical NF-kappaB pathway in survival and function of T lymphocytes
$385,000David C Parker · Oregon Health & Science University · R01 · FY2011 · AI
Preclinical Pharmacogenomics and Synaptic Biomarkers for Alzheimer's Disease
$385,000Gregory M Cole · University Of California Los Angeles · R01 · FY2011 · AT
Gene-engineered stem cell memory T-cells with anti-HIV chimeric antigen receptors
$385,000Masakazu Kamata · University Of California Los Angeles · R01 · FY2018 · AI